CVRx, Inc. CVRX
Medical/Dental Instruments · IPO 2021 · data as of November 13, 2026
CVRx, Inc. (CVRX) is a healthcare company listed in the US with a market value of about $17M. In the twelve months to September 30, 2026 it had revenue of $60M and net income of -$53M, a net margin of -88.3%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 56% a year, a 5-year average ROIC of -34%.
About CVRx
CVRx is listed in the US and classified in medical/dental instruments, IPO year 2021. Revenue went from $6M in 2020 to $57M in 2025, growth of about 56.4% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 27% over three years (dilution for shareholders). It spends 20% of revenue on research and development.
Score: 1.0 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $60M | $57M | $51M | $39M | $22M | $13M | $6M |
| Net income | -$53M | -$53M | -$60M | -$41M | -$41M | -$43M | -$14M |
| Free cash flow | -$42M | -$41M | -$41M | -$40M | -$43M | -$29M | -$16M |
| EPS (diluted) | $-2.00 | $-2.04 | $-2.65 | $-1.99 | $-2.02 | $-4.16 | $-37.01 |
| Net margin | -88.3% | -94.1% | -116.9% | -104.8% | -184.4% | -330.4% | -233.1% |
| ROIC | — | -56.7% | -38.5% | -31.7% | -28.9% | -14.1% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does CVRx pay a dividend?
Not currently.
Is CVRx a good stock to buy?
We do not give buy or sell advice. CVRx scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.